Search results
Billionaire Groupon Founder Eric Lefkofsky’s Health Tech Company Goes Public—His Fourth IPO
Forbes· 3 days agoIt’s currently his most valuable asset—and his fourth company to go public. Shares of the company...
Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with...
TechCrunch· 3 days agoTempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously...
Tempus AI prices US IPO at over $6 billion valuation
Reuters via Yahoo Finance· 4 days agoThe genetics-testing company priced its IPO at the higher end of is targeted range of $35 to $37, valuing the firm at about $6.10 billion, based on the...
TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today
InvestorPlace· 3 days agoOne of the season’s most highly anticipated initial public offerings (IPOs) is taking place today....
AI health-tech company Tempus raises $410 million in IPO - Chicago Business Journal
The Business Journals· 3 days agoTempus AI Inc., a health care technology company that leverages artificial intelligence to analyze...
Tempus AI Surges in Nasdaq Debut Following IPO
Investopedia via Yahoo Finance· 3 days agoET, a rise of 3.5%. The company sold 11.1 million shares in the IPO, and the $37-per-share price was at the high end of its target range of $35 to $37.
How To Grow From A Founder To A CEO
Forbes· 5 days agoIn 2010, perhaps no company in the world was making a bigger splash than Groupon. In less than two years since its founding, the startup reached a $1.35...
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
CNBC· 3 days agoTempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help...
Tempus shares rise in first day of trading
Crain s Chicago Business· 3 days agoTempus sold shares to institutional investors yesterday at $37 per share, the high end of its expected range. It’s the second Chicago-area IPO this year ...
Tempus AI prices its IPO at high end of range
Market Watch· 4 days agoPrecision medicine company Tempus AI said its initial public offering of 11.1 million shares priced at $37 each, compared with an estimated range of $35 to $37.
